Avinger to Present at Oppenheimer Healthcare Conference on March 20
REDWOOD CITY, CA / ACCESSWIRE / March 1, 2019 / Avinger, Inc. (NASDAQ: AVGR), a…
REDWOOD CITY, CA / ACCESSWIRE / March 1, 2019 / Avinger, Inc. (NASDAQ: AVGR), a…
Uses proprietary chemoprobe technology to demonstrate target engagement, key to drug development and rational dosing…
TORONTO, ON / ACCESSWIRE / February 27, 2019 / Itoco Inc (OTC PINK: ITMC), has…
– Preliminary data suggests the addition of HS-110 to Nivolumab may restore responsiveness to treatment…
PHASE II CLINICAL TRIAL ON PERSISTENT CHRONIC COUGH HAMBURG, GERMANY / ACCESSWIRE / February 28,…
Theralase Achieves Third Place in the Clean Technology and Life Sciences Category on the 2019…
VANCOUVER, BC / ACCESSWIRE / February 28, 2019 / EVITRADE Health Systems Corp. (CSE: EVA,…
DALLAS, TX / ACCESSWIRE / February 26, 2019 / What if there was a way…
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / February 27, 2019 / MorphoSys AG (FSE: MOR)…
Data identifies a simple blood test that predicts clinical response to pelareorep CALGARY, AB and…